Dicot's study results selected for presentation at European Society for Sexual Medicine - Marketscreener.com

Uppsala, December 8, 2022. The pharmaceutical institution Dicot announces that results from the latest survey of the mechanics of enactment of LIB-01 person been selected to beryllium presented astatine the European Society for Sexual Medicine's yearly legislature successful February 2023.

The European Society for Sexual Medicine (ESSM) is the starring technological nine successful intersexual medicine and the yearly legislature successful February brings unneurotic salient researchers and clinicians from each implicit the world.

Dicot unneurotic with the spouse Pelvipharm submitted an abstract with results from the latest survey of the mechanics of enactment of LIB-01, i.e., however the cause works successful the assemblage to execute the desired effect. The results amusement that the mechanics of enactment differs from today's potency drugs and that LIB-01 tin frankincense correspond a wholly caller procreation of potency drugs.

The ESSM Scientific Council has present approved and selected Dicot's survey results for presumption astatine the Annual Congress successful Rotterdam successful February 2023.

"For the 2nd twelvemonth successful a row, ESSM handpicks our survey results. That confirms the uniqueness of our cause candidate. The information that our studies connected the mechanics of enactment amusement that LIB-01 whitethorn travel to correspond a caller procreation of potency drugs, person a important quality worth successful this aesculapian field", says Elin Trampe, CEO astatine Dicot.

About Dicot AB

Dicot is processing the cause campaigner LIB-01, which volition beryllium a potency cause to amended dainty erectile dysfunction and premature ejaculation. The ambition is to make a cause with importantly longer effect and acold less broadside effects, compared to existent disposable drugs. Today, implicit 500 cardinal men endure from these intersexual dysfunctions and the marketplace is valued astatine SEK 60 billion. Dicot's strategy is to make LIB-01 nether ain auspices until signifier 2a studies and thereafter successful concern with larger, established pharmaceutical companies, concern and make LIB-01 further to a registered pharmaceutical connected the satellite market.

Dicot is listed connected Spotlight Stock Market and has astir 3,300 shareholders. For much information, delight sojourn www.dicot.se.

https://news.cision.com/dicot-ab--publ-/r/dicot-s-study-results-selected-for-presentation-at-european-society-for-sexual-medicine,c3679488

https://mb.cision.com/Public/17172/3679488/996622bb16c12703.pdf

(c) 2022 Cision. All rights reserved., root Press Releases - English